Long-Chain Polyunsaturated Fatty Acids in Breast Milk
The need for long-chain polyunsaturated fatty acids (LC-PUFA), such as docosahexaenoic acid (DHA, C22:6n3) and arachidonic acid (AA, C20:4n6), in the diet of infants in order to achieve full developmental potential is a matter of intense investigation by several research groups worldwide. It has been widely reported that breast-fed infants perform better on tests that assess neurodevelopmental outcomes than do formula-fed infants. Although human milk contains LC-PUFA that are absent from formula, it is necessary to demonstrate that any beneficial effects of human milk on infant development are purely attributed to the presence of LC-PUFA in human milk and their absence from formula to establish causality. The hypothesis that dietary DHA is associated with developmental outcome needs to be plausible; the effect must be consistent, specific, and independent of confounding factors. The hypothesis is certainly plausible. DHA is avidly incorporated and retained in brain cerebral phospholipids, and a most consistent finding has been the lower level of cerebral DHA in the brains of formula-fed infants (receiving no DHA) relative to those fed human milk (receiving DHA). The formula-fed infants in these studies were generally fed formulas with adequate a-linolenic acid levels, and this may indicate a nutritional requirement for preformed DHA.
Several studies have compared the effects of breast-and formula-feeding on functional outcomes in preterm and term infants. While many of the outcomes have involved visual testing, others have attempted more global assessments. The results have shown differences in favor of breast-feeding but have been colored by the strong socioeconomic differences between mothers who choose to breast feed and those who choose formula-feeding.
Randomized clinical trials involving preterm infants have shown a clear requirement for DHA for full visual and neural development. These results are consistent with primate studies. However, intervention studies with term infants that have attempted to improve the DHA supply of infant formula and hence infant development have not yielded consistent results. Some randomized studies have demonstrated improved visual and developmental indices in supplemented over unsupplemented infants, others have failed to demonstrate an effect. This disparity could be due to methodological and environmental differences. It is also notable that supplemental regimens have not specifically added DHA and have included other LC-PUFA, raising the question as to the specificity of the effect. However, only tissue DHA levels have consistently correlated with outcomes.
KeywordsPreterm Infant Human Milk Essential Fatty Acid Infant Formula Chain Polyunsaturated Fatty Acid
Unable to display preview. Download preview PDF.
- Auestad N, Montalto MB, Hall RT, Fitzgerald KM, Wheeler RE, Connor WE, Neuringer M, Connor SL, Taylor JA, Hartmann EE. Visual acuity, erythrocyte fatty acid composition, and growth in term infants fed formulas with long chain polyunsaturated fatty acids for one year. Pediatr Res 1997; 41:1–10.PubMedCrossRefGoogle Scholar
- Birch DG, Birch EE, Hoffman DR, Uauy RD. Retinal development in very-low-birth-weight infants fed diets differing in omega-3 fatty acids. Invest Ophthalmol Vis Sci 1992a;33:2365–2376.Google Scholar
- Birch EE, Birch DG, Hoffman DR, Uauy R. Dietary essential fatty acid supply and visual acuity development. Invest Ophthalmol Vis Sci 1992b;32:3242–3253.Google Scholar
- Birch EE, Birch DG, Hoffman DR, Uauy R, Bane MC, Castaneda YS, Wheaton D, Prestidge CB. Visual maturation of term infants fed omega-3 long chain polyunsaturated fatty acid (LC-PUFA) supplemented formula. Invest Ophthalmol Vis Sci 1996;37:S1112.Google Scholar
- Carlson SE, Werkman SH, Rhodes PG, Tolley EA. Visual-acuity development in healthy preterm infants: effect of marine-oil supplementation. Am J Clin Nutr 1993a;58:35–42.Google Scholar
- Combs GF Jr. Should intakes with beneficial actions, often requiring supplementation, be considered for RDAs? J Nutr 1996;126:23735–23765.Google Scholar
- Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer, Cannon JG, Rogers TS, Klempner MS, Weber PC, Schaefer EJ, Wolff SM, Dinarello CA. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989;320:265–271.PubMedCrossRefGoogle Scholar
- Gibson R, Neumann M, Makrides M. A randomised clinical trial of long chain polyunsaturated fatty acid supplementation in term infants: effect on neural indices. Inform 1997a;5A.Google Scholar
- Jensen RG. The Lipids of Human Milk. Boca Raton FL: CRC Press; 1989. p 213.Google Scholar
- Jorgensen MH, Hernell 0, Lund P, Holmer G, Michaelsen KF Visual acuity of 4 months term infants in relation to DHA intake; a randomised study. [Abstract] J Pediatr Gastroenterol Nutr 1996;22:436A.Google Scholar
- Makrides M, Gibson RA. Are long chain polyunsaturated fatty acids essential nutrients in infancy? In: Riemersma RA, editor. Essential Fatty Acids and Eicosanoids. Invited papers from the 46International Congress on Essential Fatty Acids and Eicosanoids. Edinburgh, Scotland; July 20–24, 1997. Champaign IL: AOCS Press; 1998.Google Scholar
- Makrides M, Simmer K, Neumann M, Gibson R. Changes in the polyunsaturated fatty acids of breast milk from mothers of full-term infants over 30wk of lactation. Am J Clin Nutr 1995a;61:1231–1233.Google Scholar
- Neuringer M, Connor WE, Lin DS, Barstad L, Luck S. Biochemical and functional effects of prenatal and postnatal omega-3 fatty acid deficiency on retina and brain in rhesus monkeys. Proc Natl Acad Sci USA 1986;83:4021–4025.Google Scholar
- Taylor KB, Anthony LE, editors. Clinical Nutrition. New York: McGraw-Hill; 1983. p 631.Google Scholar